626 related articles for article (PubMed ID: 6318770)
21. Alteration of methylcholanthrene-mediated suppression of cutaneous delayed hypersensitivity by benzoflavone treatment of C57BL/6J mice.
Frank DM; Blumer JL
Toxicol Appl Pharmacol; 1988 Aug; 95(1):72-81. PubMed ID: 2842891
[TBL] [Abstract][Full Text] [Related]
22. Genetic dependence of hepatic microsome-mediated depression of aflatoxin B1 activation to mutagens in Ames Salmonella typhimurium TA-98 system.
Raina V; Gurtoo HL; Berrigan M; Paigen B
Biochem Biophys Res Commun; 1980 Jun; 94(3):737-43. PubMed ID: 6772179
[No Abstract] [Full Text] [Related]
23. Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors.
Mason ME; Okey AB
Cancer Res; 1981 Jul; 41(7):2778-82. PubMed ID: 6265068
[TBL] [Abstract][Full Text] [Related]
24. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes.
Daniels JM; Massey TE
Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185
[TBL] [Abstract][Full Text] [Related]
25. Effects of phenobarbital, 3-methylcholanthrene and beta-naphthoflavone pretreatment on mouse liver microsomal enzymes and on metabolite patterns of benzo[a]pyrene.
Wang IY
Biochem Pharmacol; 1981 Jun; 30(11):1337-43. PubMed ID: 6268094
[No Abstract] [Full Text] [Related]
26. Acquisition of aryl hydrocarbon hydroxylase inducibility by aromatic hydrocarbons in monolayer-cultured hepatocytes from nonresponsive mouse strains.
Nemoto N; Sakurai J; Tazawa A; Ishikawa T
Cancer Res; 1990 Jun; 50(11):3226-30. PubMed ID: 1692256
[TBL] [Abstract][Full Text] [Related]
27. Protection against tumorigenesis by 3-methylcholanthrene in mice by beta-naphthoflavone as a function of inducibility of methylcholanthrene metabolism.
Anderson LM; Seetharam S
Cancer Res; 1985 Dec; 45(12 Pt 1):6384-9. PubMed ID: 4063988
[TBL] [Abstract][Full Text] [Related]
28. In vivo effect of 7,8-benzoflavone on aryl hydrocarbon hydroxylase activity of mouse liver microsomes.
Kiyohara C; Hirohata T
Toxicol Lett; 1993 Feb; 66(2):199-207. PubMed ID: 8430440
[TBL] [Abstract][Full Text] [Related]
29. Benzo[e]pyrene pretreatment of immature, female C57BL/6J mice results in increased bioactivation of aflatoxin B1 in vitro.
Ma XF; Gibbons JA; Babish JG
Toxicol Lett; 1991 Dec; 59(1-3):51-8. PubMed ID: 1755035
[TBL] [Abstract][Full Text] [Related]
30. Oocyte destruction by polycyclic aromatic hydrocarbons is not linked to the inducibility of ovarian aryl hydrocarbon (benzo(a)pyrene) hydroxylase activity in (DBA/2N X C57BL/6N) F1 X DBA/2N backcross mice.
Mattison DR; Nightingale MS
Pediatr Pharmacol (New York); 1982; 2(1):11-21. PubMed ID: 7110752
[TBL] [Abstract][Full Text] [Related]
31. Differential induction of fetal mouse liver and lung cytochromes P-450 by beta-naphthoflavone and 3-methylcholanthrene.
Miller MS; Jones AB; Chauhan DP; Park SS; Anderson LM
Carcinogenesis; 1989 May; 10(5):875-91. PubMed ID: 2468428
[TBL] [Abstract][Full Text] [Related]
32. Ah receptor in mice genetically "nonresponsive" for cytochrome P4501A1 induction: cytosolic Ah receptor, transformation to the nuclear binding state, and induction of aryl hydrocarbon hydroxylase by halogenated and nonhalogenated aromatic hydrocarbons in embryonic tissues and cells.
Harper PA; Golas CL; Okey AB
Mol Pharmacol; 1991 Nov; 40(5):818-26. PubMed ID: 1658612
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes in vitro.
Metcalfe SA; Colley PJ; Neal GE
Chem Biol Interact; 1981 May; 35(2):145-57. PubMed ID: 6783328
[TBL] [Abstract][Full Text] [Related]
34. Benzo(a)pyrene metabolism in hepatic microsomes from feral and 3-methycholanthrene-treated southern flounder, Paralichthys lethostigma.
Little PJ; James MO; Pritchard JB; Bend JR
J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):309-20. PubMed ID: 6520733
[TBL] [Abstract][Full Text] [Related]
35. Binding of benzo(a)pyrene and dibenz(a,h)anthracene to the Ah receptor in mouse and rat hepatic cytosols.
Okey AB; Dubé AW; Vella LM
Cancer Res; 1984 Apr; 44(4):1426-32. PubMed ID: 6322977
[TBL] [Abstract][Full Text] [Related]
36. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes.
Shimada T; Nakamura S; Imaoka S; Funae Y
Toxicol Appl Pharmacol; 1987 Oct; 91(1):13-21. PubMed ID: 3118508
[TBL] [Abstract][Full Text] [Related]
37. Identification and mutagenicity of aflatoxicol-M1 produced by metabolism of aflatoxin B1 and aflatoxicol by liver fractions from rainbow trout (Salmo gairdneri) fed beta-naphthoflavone.
Loveland PM; Coulombe RA; Libbey LM; Pawlowski NE; Sinnhuber RO; Nixon JE; Bailey GS
Food Chem Toxicol; 1983 Oct; 21(5):557-62. PubMed ID: 6418626
[TBL] [Abstract][Full Text] [Related]
38. Effects of various inducers on the activities of cytochrome P-450-mixed function oxidases and aflatoxin B1 activation in microsomes of hamster livers.
Sunouchi M; Fukuhara M; Ohno Y; Takanaka A
J Toxicol Sci; 1988 Nov; 13(4):193-204. PubMed ID: 3149679
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes.
Wood AW; Levin W; Lu AY; Yagi H; Hernandez O; Jerina DM; Conney AH
J Biol Chem; 1976 Aug; 251(16):4882-90. PubMed ID: 821945
[TBL] [Abstract][Full Text] [Related]
40. Mutagenesis of certain activated carcinogens in vitro associated with genetically mediated increases in monooxygenase activity and cytochrome P 1-450.
Felton JS; Nebert DW
J Biol Chem; 1975 Sep; 250(17):6769-78. PubMed ID: 808546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
